← Back to Search

Skin Testing Arm for Penicillin Allergy

Phase 4
Waitlist Available
Led By Jonathan M Zenilman
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Prior history of PCN allergy
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights

Study Summary

This trial will help to determine whether penicillin allergy testing can be used to safely treat STD patients.

Eligible Conditions
  • Penicillin Allergy

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check β€œYes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Respondents Who Responded YES to Any Question Defining High Risk Penicillin Allergy Using Questionnaire Developed by the Study
Safety of Direct Oral Challenge Defined by Number of Subjects Who Did Not Have Pre-defined Changes in Vital Signs or Pre-defined Emergence of New Respiratory or Skin Symptoms After Oral Challenge
Secondary outcome measures
Patient Acceptability of PCN Testing/Oral Challenge Assessed by a Study Team Developed Questionnaire
Provider Assessment of Feasibility of Allergy Evaluation at the End of Study

Trial Design

2Treatment groups
Active Control
Group I: Skin Testing ArmActive Control2 Interventions
These subjects with reported PCN allergy and reported low risk responses will receive skin testing followed by oral challenge
Group II: Direct Oral ChallengeActive Control1 Intervention
These subjects with reported PCN allergy and low risk responses will bypass skin testing and have direct oral challenge with amoxicillin

Find a Location

Who is running the clinical trial?

University of WashingtonOTHER
1,741 Previous Clinical Trials
1,847,482 Total Patients Enrolled
Louisiana State University Health Sciences Center in New OrleansOTHER
114 Previous Clinical Trials
43,917 Total Patients Enrolled
Johns Hopkins UniversityLead Sponsor
2,266 Previous Clinical Trials
14,837,213 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many centers is this experiment operating in?

"Currently, 4 clinical sites are looking to enroll patients for this trial. Potential participants can choose from New Orleans, Indianapolis and Seattle as well as four additional locations nearby. To decrease the amount of travel necessary, it is prudent to select a site that is proximate to your current home."

Answered by AI

What ailments is Skin Testing Arm most commonly prescribed for?

"Skin Testing Arm is typically administered to treat gram-negative bacterial infections. Additionally, it can help with persistent facial erythema, rhinorrhoea, and nasal intubation issues."

Answered by AI

Is this research opportunity available to participants currently?

"Affirmative. Clinicaltrials.gov hosts the data which proves that this clinical trial, first posted on June 1st 2021, is actively recruiting volunteers. Around a thousand participants need to be found from 4 distinct medical facilities."

Answered by AI

What is the maximum capacity for this research study's participation?

"This clinical trial necessitates 1000 participants who fulfill the pre-defined requirements. Potential volunteers can join from two locations, namely Louisiana State University's medical centre in New Orleans and Indiana University's facility in Indianapolis."

Answered by AI
~74 spots leftby Apr 2025